Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$63.74 USD
+1.37 (2.20%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $63.73 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/23/24 |
---|---|
Current Quarter | 0.68 |
EPS Last Quarter | 0.70 |
Last EPS Surprise | 0.00% |
ABR | 2.32 |
Earnings ESP
|
-0.03% |
---|---|
Current Year | 2.71 |
Next Year | 2.89 |
EPS (TTM) | 2.59 |
P/E (F1) | 23.00 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.61B | 1.69B | 6.45B | 6.81B |
# of Estimates | 4 | 12 | 12 | 12 |
High Estimate | 1.61B | 1.70B | 6.56B | 7.22B |
Low Estimate | 1.60B | 1.67B | 6.20B | 5.92B |
Year ago Sales | 1.48B | 1.53B | 6.00B | 6.45B |
Year over Year Growth Est. | 8.72% | 9.95% | 7.47% | 5.51% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.68 | 0.69 | 2.71 | 2.89 |
# of Estimates | 13 | 11 | 13 | 13 |
Most Recent Consensus | 0.69 | 0.56 | 2.62 | 3.10 |
High Estimate | 0.70 | 0.73 | 2.77 | 3.11 |
Low Estimate | 0.67 | 0.56 | 2.56 | 2.30 |
Year ago EPS | 0.59 | 0.64 | 2.51 | 2.71 |
Year over Year Growth Est. | 15.25% | 7.81% | 7.97% | 6.48% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 3 | 0 | 1 | 0 |
Up Last 30 Days | 3 | 0 | 1 | 0 |
Up Last 60 Days | 3 | 0 | 1 | 0 |
Down Last 7 Days | 5 | 9 | 9 | 10 |
Down Last 30 Days | 6 | 9 | 9 | 10 |
Down Last 60 Days | 6 | 9 | 9 | 10 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.68 | 0.69 | 2.71 | 2.89 |
7 Days Ago | 0.69 | 0.73 | 2.77 | 3.11 |
30 Days Ago | 0.69 | 0.73 | 2.77 | 3.11 |
60 Days Ago | 0.69 | 0.73 | 2.77 | 3.11 |
90 Days Ago | 0.69 | 0.73 | 2.77 | 3.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.68 | 0.68 | 2.70 | 2.82 |
Zacks Consensus Estimate | 0.68 | 0.69 | 2.71 | 2.89 |
Earnings ESP | -0.03% | -1.25% | -0.60% | -2.27% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.70 | 0.66 | 0.64 | 0.59 | NA |
Estimate | 0.70 | 0.64 | 0.64 | 0.59 | NA |
Difference | 0.00 | 0.02 | 0.00 | 0.00 | 0.01 |
Surprise | 0.00% | 3.13% | 0.00% | 0.00% | 0.78% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more